PATHOLOGIC PROCESSES
Clinical trials for PATHOLOGIC PROCESSES explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC PROCESSES trials appear
Sign up with your email to follow new studies for PATHOLOGIC PROCESSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI takes over oxygen delivery in hospitals – could save lives?
Disease control CompletedThis study tested a smart, automated oxygen system (O2matic PRO100) in 300 hospitalized adults with serious injuries or illnesses. The goal was to see if the machine could keep oxygen levels in a safe range better than standard manual methods. The approach aims to prevent both to…
Matched conditions: PATHOLOGIC PROCESSES
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug MRX-2843 tested in patients with Hard-to-Treat cancers
Disease control CompletedThis early-stage study tested a new drug called MRX-2843 in 42 adults with advanced solid tumors that had come back or stopped responding to standard treatments. The main goal was to check the drug's safety and find the best dose. Researchers monitored side effects and how the dr…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Stem cell shots before amputation aim to save limbs
Disease control CompletedThis early-phase study tested whether injecting donor stem cells into the leg before amputation could prevent wound complications and reduce the need for further surgery. 81 adults aged 40-90 with severe leg artery disease received the injections. The main goal was to check safet…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Indiana University • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New malaria drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study tested a new experimental drug called MMV367 in 12 healthy adults who were intentionally infected with the malaria parasite. The goal was to see how the drug works in the body and how well it clears the parasite. Participants were closely monitored and given standard m…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated May 17, 2026 03:10 UTC
-
HIV study probes hidden clotting risks
Knowledge-focused CompletedThis study collected blood samples from 310 HIV-infected adults and healthy volunteers to measure markers of inflammation, blood clotting, and blood vessel function. The goal was to better understand how these markers relate to HIV and risks like heart disease or stroke. No treat…
Matched conditions: PATHOLOGIC PROCESSES
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 17, 2026 02:56 UTC